Esmolol is a class II antiarrhythmic drug used to prevent and treat tachycardia and acute supraventricular tachycardia. Esmolol hydrochlorlde injection is used for the short-term treatment of tachycardia and hypertension during surgery.
Esmolol Hydrochloride Market contains market size and forecasts of Esmolol Hydrochloride in global, including the following market information:
- Global Esmolol Hydrochloride Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global Esmolol Hydrochloride Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Esmolol Hydrochloride companies in 2021 (%)
The global Esmolol Hydrochloride market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
1ml:0.1g Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Esmolol Hydrochloride include Abraxis BioScience(Celgene), Hikma Pharmaceuticals, Baxter International, General Injectables and Vaccines, Bayer, Bioniche Pharma and Qilu Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Esmolol Hydrochloride manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Esmolol Hydrochloride Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Esmolol Hydrochloride Market Segment Percentages, by Type, 2021 (%)
Global Esmolol Hydrochloride Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Esmolol Hydrochloride Market Segment Percentages, by Application, 2021 (%)
Global Esmolol Hydrochloride Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Esmolol Hydrochloride Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Esmolol Hydrochloride revenues in global market, 2017-2022 (Estimated), ($ millions)
- Key companies Esmolol Hydrochloride revenues share in global market, 2021 (%)
- Key companies Esmolol Hydrochloride sales in global market, 2017-2022 (Estimated), (K Units)
- Key companies Esmolol Hydrochloride sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Abraxis BioScience(Celgene)
- Hikma Pharmaceuticals
- Baxter International
- General Injectables and Vaccines
- Bayer
- Bioniche Pharma
- Qilu Pharmaceutical
Industry Market Size
